During the past decade, Prisma Health Cancer Institute - Spartanburg conducted 167 clinical trials. In the 10-year time frame, 167 clinical trials started and 113 clinical trials were completed, i.e. on average, 67.7% percent of trials that started reached the finish line to date. In the past 5 years, 47 clinical trials started and 80 clinical trials were completed. i.e. 170.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Prisma Health Cancer Institute - Spartanburg" #1 sponsor was "National Cancer Institute (NCI)" with 99 trials, followed by "SWOG Cancer Research Network" with 46 trials sponsored, "Alliance for Clinical Trials in Oncology" with 42 trials sponsored, "NRG Oncology" with 18 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 18 trials sponsored. Other sponsors include 36 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Prisma Health Cancer Institute - Spartanburg" #1 collaborator was "National Cancer Institute (NCI)" with 151 trials as a collaborator, "NRG Oncology" with 27 trials as a collaborator, "Canadian Cancer Trials Group" with 12 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator and "SWOG Cancer Research Network" with 4 trials as a collaborator. Other collaborators include 43 different institutions and companies that were collaborators in the rest 42 trials.

According to Clinical.Site data, the most researched conditions in "Prisma Health Cancer Institute - Spartanburg" are "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Breast Cancer" (8 trials), "Recurrent Ovarian Carcinoma" (8 trials), "Stage IV Lung Cancer AJCC v8" (8 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials). Many other conditions were trialed in "Prisma Health Cancer Institute - Spartanburg" in a lesser frequency.

Most popular intervention types in "Prisma Health Cancer Institute - Spartanburg" are "Drug" (189 trials), "Other" (173 trials), "Biological" (84 trials), "Procedure" (50 trials) and "Radiation" (45 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (88 trials), "Quality-of-Life Assessment" (67 trials), "Questionnaire Administration" (44 trials), "Cisplatin" (27 trials) and "Paclitaxel" (25 trials). Other intervention names were less common.

The vast majority of trials in "Prisma Health Cancer Institute - Spartanburg" are 199 trials for "All" genders, 47 trials for "Female" genders and 13 trials for "Male" genders.

Currently, there are NaN active trials in "Prisma Health Cancer Institute - Spartanburg". undefined are not yet recruiting, 54 are recruiting, 122 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 60 completed trials in Prisma Health Cancer Institute - Spartanburg, 5 suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in Prisma Health Cancer Institute - Spartanburg, 5 "Phase 1" clinical trials were conducted, 109 "Phase 2" clinical trials and 132 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 14 trials that are defined as “Not Applicable".